Abstract
Numerous state laws and the federal Genetic Information Nondiscrimination Act (GINA) have been enacted to prevent or redress genetic discrimination in employment and health insurance. In 2020, Florida became the first state to prohibit life insurance companies from using the results of presymptomatic genetic tests in underwriting. A relatively unexamined issue is whether laws such as Florida enacted can reduce mortality rates by increasing the willingness of at-risk individuals to have genetic testing.